Breaking News Instant updates and real-time market news.

MNK

Mallinckrodt

$4.85

0.035 (0.73%)

17:03
08/13/19
08/13
17:03
08/13/19
17:03

Mallinckrodt announces publication of results from Phase 1b trial of StrataGraft

Mallinckrodt announced publication of results of its Phase 1b clinical trial of StrataGraft, an investigational regenerative tissue, in Burns, the journal of the International Society for Burn Injuries, or ISBI. Study data showed that treatment with a single application of StrataGraft tissue resulted in wound closure by three months in 27 of 29 study participants. None of these 27 study participants required the harvest of donor skin (autograft) by 28 days after application. Additionally, the observed characteristics of the wounds treated with StrataGraft were comparable to those treated with autograft at 12 months after treatment. The safety and effectiveness of StrataGraft have not yet been established by the FDA.

  • 04

    Sep

  • 09

    Sep

MNK Mallinckrodt
$4.85

0.035 (0.73%)

06/14/19
ADAM
06/14/19
NO CHANGE
Target $22
ADAM
Buy
Mallinckrodt price target lowered to $22 from $37 at Canaccord
Canaccord analyst Dewey Steadman lowered his price target on Mallinckrodt to $22 from $37 following the company's release of a blinded RA study showing Acthar's effectiveness. The analyst noted the data is the first of a string of expected Acthar data reads that he thinks can bolster and justify Acthar's use for exacerbations in highly refractory immune-modulated conditions. The price target reduction is based on a lower expected contribution from pipeline products. Steadman maintained his Buy rating on Mallinckrodt shares.
07/11/19
JEFF
07/11/19
NO CHANGE
Target $10
JEFF
Hold
Mallinckrodt price target lowered to $10 from $15 at Jefferies
Jefferies analyst Anthony Petrone lowered his price target for Mallinckrodt to $10 from $15 saying the latest Symphony Health prescription data show Acthar declines accelerating to mid-teens since the Centers for Medicare and Medicaid Services announced intentions to reduce the Medicaid base date average manufacturer price in late May. Although Medicaid is only ~10% of Acthar sales, the CMS announcement appears to be having a "chilling effect" on fill rates as the injunctive relief process under the Administrative Procedure Act evolves, Petrone tells investors in a research note. He lowered his estimates to reflect "ongoing uncertainties" and keeps a Hold rating on Mallinckrodt.
07/17/19
LEHM
07/17/19
NO CHANGE
Target $11
LEHM
Overweight
Mallinckrodt halted trial 'further clouds' Acthar growth, says Barclays
Barclays analyst Balaji Prasad maintains an Equal Weight rating on Mallinckrodt with an $11 price target after the company permanently discontinued its Phase 2b study of Acthar in patients with amyotrophic lateral sclerosis. The trial result raises some uncertainty over increased Acthar utilization that may have followed positive clinical readouts, Prasad tells investors in a research note. Further, he believes the halted study "further clouds" the Acthar growth outlook.
08/12/19
RHCO
08/12/19
NO CHANGE
Target $7
RHCO
Hold
Mallinckrodt price target lowered to $7 from $10 at SunTrust
SunTrust analyst Gregg Gilbert lowered his price target on Mallinckrodt to $7 and kept his Hold rating after its Q2 results and lower Acthar sales. The analyst warns that investors will remain cautious on the stock amid the continued uncertainty around its potential opioid liability, even though the company's cash flow, debt reduction, and "good growth" in its Hospital business were the bright spots for the quarter. Gilbert further cites the positive performance and long-term potential of Mallinckrodt's Inomax franchise in spite of its competitive threats.

TODAY'S FREE FLY STORIES

ONE

OneSmart

$7.03

-0.355 (-4.81%)

05:36
08/19/19
08/19
05:36
08/19/19
05:36
Hot Stocks
OneSmart announces CEO share purchase plan »

OneSmart announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WB

Weibo

$37.05

1.69 (4.78%)

05:34
08/19/19
08/19
05:34
08/19/19
05:34
Earnings
Breaking Earnings news story on Weibo »

Weibo sees Q3 revenue up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

WB

Weibo

$37.05

1.69 (4.78%)

05:34
08/19/19
08/19
05:34
08/19/19
05:34
Earnings
Weibo reports Q2 EPS 68c, consensus 59c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

SINA

Sina

$37.66

1.97 (5.52%)

05:32
08/19/19
08/19
05:32
08/19/19
05:32
Earnings
Sina reports Q2 EPS 76c, consensus 47c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

05:25
08/19/19
08/19
05:25
08/19/19
05:25
General news
FX Action: The yen has nudged lower »

FX Action: The yen has…

05:20
08/19/19
08/19
05:20
08/19/19
05:20
General news
FX Action: The yen has nudged lower »

FX Action: The yen has…

TWTR

Twitter

$40.58

0.47 (1.17%)

04:55
08/19/19
08/19
04:55
08/19/19
04:55
Conference/Events
Twitter management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 20

    Aug

  • 20

    Aug

  • 24

    Sep

AVY

Avery Dennison

$113.94

2.305 (2.06%)

04:55
08/19/19
08/19
04:55
08/19/19
04:55
Conference/Events
Avery Dennison management to meet with Loop Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 20

    Aug

  • 21

    Aug

CHH

Choice Hotels

$88.24

0.7 (0.80%)

04:55
08/19/19
08/19
04:55
08/19/19
04:55
Conference/Events
Choice Hotels management to meet with Morgan Stanley »

Group Luncheon Meeting to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

PAYS

Paysign

$13.94

0.12 (0.87%)

04:55
08/19/19
08/19
04:55
08/19/19
04:55
Recommendations
Paysign analyst commentary  »

Paysign management to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 20

    Aug

  • 21

    Aug

  • 26

    Aug

  • 27

    Aug

  • 28

    Aug

APHA

Aphria

$6.17

0.23 (3.87%)

04:55
08/19/19
08/19
04:55
08/19/19
04:55
Conference/Events
Aphria management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 20

    Aug

MCO

Moody's

$214.29

4.42 (2.11%)

04:55
08/19/19
08/19
04:55
08/19/19
04:55
Conference/Events
Moody's management to meet with MKM Partners »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 20

    Aug

NCMGY

Newcrest Mining

$0.00

(0.00%)

04:55
08/19/19
08/19
04:55
08/19/19
04:55
Conference/Events
Newcrest Mining management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 20

    Aug

  • 21

    Aug

NPO

EnPro

$61.93

2.13 (3.56%)

04:55
08/19/19
08/19
04:55
08/19/19
04:55
Conference/Events
EnPro management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 20

    Aug

  • 21

    Aug

RMD

ResMed

$134.45

2.06 (1.56%)

04:55
08/19/19
08/19
04:55
08/19/19
04:55
Conference/Events
ResMed management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 26

    Aug

  • 05

    Nov

  • 06

    Nov

ZNGA

Zynga

$5.56

0.025 (0.45%)

04:55
08/19/19
08/19
04:55
08/19/19
04:55
Conference/Events
Zynga management to meet with Wedbush »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 13

    Nov

CCMP

Cabot Microelectronics

$122.73

4.24 (3.58%)

04:55
08/19/19
08/19
04:55
08/19/19
04:55
Conference/Events
Cabot Microelectronics management to meet with Loop Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

04:55
08/19/19
08/19
04:55
08/19/19
04:55
General news
Breaking General news story  »

3-Month Bill Auction to…

QMCO

Quantum

$0.00

(0.00%)

04:55
08/19/19
08/19
04:55
08/19/19
04:55
Conference/Events
Quantum management to meet with B. Riley FBR »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 20

    Aug

  • 21

    Aug

  • 12

    Sep

GKOS

Glaukos

$63.02

2.385 (3.93%)

04:55
08/19/19
08/19
04:55
08/19/19
04:55
Conference/Events
Glaukos management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 26

    Aug

  • 04

    Sep

  • 13

    Nov

04:55
08/19/19
08/19
04:55
08/19/19
04:55
General news
Breaking General news story  »

6-Month Bill Auction to…

BCEI

Bonanza Creek

$22.76

1.61 (7.61%)

04:55
08/19/19
08/19
04:55
08/19/19
04:55
Conference/Events
Bonanza Creek management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 20

    Aug

FFIN

First Financial

$31.15

0.78 (2.57%)

04:55
08/19/19
08/19
04:55
08/19/19
04:55
Recommendations
First Financial analyst commentary  »

First Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 23

    Sep

  • 26

    Sep

  • 27

    Sep

SF

Stifel Financial

$52.18

0.925 (1.80%)

04:55
08/19/19
08/19
04:55
08/19/19
04:55
Conference/Events
Stifel Financial management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 20

    Aug

AU

AngloGold

$21.04

0.7 (3.44%)

04:55
08/19/19
08/19
04:55
08/19/19
04:55
Conference/Events
AngloGold management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 20

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.